User contributions

Jump to navigation Jump to search
Search for contributionsExpandCollapse
⧼contribs-top⧽
⧼contribs-date⧽

(newest | oldest) View ( | ) (20 | 50 | 100 | 250 | 500)

  • 07:14, 25 October 2016 diff hist -3,036 m CNS lymphomaText replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
  • 07:14, 25 October 2016 diff hist -184 m Paroxysmal nocturnal hemoglobinuriaText replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase III</span>" to "style="background-color:#00CD00"|Phase III"
  • 07:13, 25 October 2016 diff hist -92 m Paroxysmal nocturnal hemoglobinuriaText replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Non-randomized</span>" to "style="background-color:#EEEE00"|Non-randomized"
  • 07:13, 25 October 2016 diff hist -276 m Transformed lymphomaText replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
  • 07:12, 25 October 2016 diff hist -92 m Myelodysplastic syndromeText replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Non-randomized</span>" to "style="background-color:#EEEE00"|Non-randomized"
  • 07:12, 25 October 2016 diff hist -184 m Burkitt lymphomaText replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase III</span>" to "style="background-color:#00CD00"|Phase III"
  • 07:11, 25 October 2016 diff hist -92 m Thyroid cancerText replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Non-randomized</span>" to "style="background-color:#EEEE00"|Non-randomized"
  • 07:11, 25 October 2016 diff hist -184 m Acquired thrombotic thrombocytopenic purpuraText replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Non-randomized</span>" to "style="background-color:#EEEE00"|Non-randomized"
  • 07:10, 25 October 2016 diff hist -460 m Penile cancerText replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
  • 07:09, 25 October 2016 diff hist -460 m Colon cancerText replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
  • 07:08, 25 October 2016 diff hist -368 m Editing test pageText replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase III</span>" to "style="background-color:#00CD00"|Phase III"
  • 07:08, 25 October 2016 diff hist -1,196 m Soft tissue sarcomaText replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
  • 07:07, 25 October 2016 diff hist -5,612 m Prostate cancerText replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase III</span>" to "style="background-color:#00CD00"|Phase III"
  • 07:07, 25 October 2016 diff hist -552 m Erdheim-Chester diseaseText replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase III</span>" to "style="background-color:#00CD00"|Phase III"
  • 07:06, 25 October 2016 diff hist -1,564 m Endometrial cancerText replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
  • 07:06, 25 October 2016 diff hist -552 m Tositumomab and I-131 (Bexxar)Text replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
  • 07:06, 25 October 2016 diff hist -276 m T-cell acute lymphoblastic leukemiaText replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
  • 07:05, 25 October 2016 diff hist -276 m Levels of EvidenceText replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
  • 07:05, 25 October 2016 diff hist -920 m Extranodal NK- and T-cell lymphoma, nasal typeText replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
  • 07:05, 25 October 2016 diff hist -1,012 m Prostate cancerText replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
  • 07:04, 25 October 2016 diff hist -92 m Waldenström macroglobulinemiaText replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase I/II</span>" to "style="background-color:#EEEE00"|Phase I/II"
  • 07:03, 25 October 2016 diff hist -552 m HIV-associated lymphomaText replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
  • 07:03, 25 October 2016 diff hist -1,104 m Marginal zone lymphomaText replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
  • 07:03, 25 October 2016 diff hist -920 m Follicular lymphoma - historicalText replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase III</span>" to "style="background-color:#00CD00"|Phase III"
  • 07:02, 25 October 2016 diff hist -92 m Chronic myeloid leukemiaText replacement - "<span style="background:#ff0000; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase I</span>" to "style="background-color:#ff0000"|Phase I"
  • 07:01, 25 October 2016 diff hist -15,548 m Breast cancerText replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase III</span>" to "style="background-color:#00CD00"|Phase III"
  • 07:01, 25 October 2016 diff hist -92 m Marginal zone lymphomaText replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Non-randomized</span>" to "style="background-color:#EEEE00"|Non-randomized"
  • 07:01, 25 October 2016 diff hist -1,840 m Small cell lung cancerText replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase III</span>" to "style="background-color:#00CD00"|Phase III"
  • 07:01, 25 October 2016 diff hist -184 m Urothelial carcinomaText replacement - "<span style="background:#ff0000; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Retrospective</span>" to "style="background-color:#ff0000"|Retrospective"
  • 07:00, 25 October 2016 diff hist -368 m Waldenström macroglobulinemiaText replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase III</span>" to "style="background-color:#00CD00"|Phase III"
  • 06:59, 25 October 2016 diff hist -1,932 m Anaplastic gliomaText replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
  • 06:59, 25 October 2016 diff hist -2,944 m Pancreatic cancerText replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase III</span>" to "style="background-color:#00CD00"|Phase III"
  • 06:59, 25 October 2016 diff hist -2,484 m Cervical cancerText replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
  • 06:58, 25 October 2016 diff hist -276 m CNS lymphomaText replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase I/II</span>" to "style="background-color:#EEEE00"|Phase I/II"
  • 06:58, 25 October 2016 diff hist -1,104 m OsteosarcomaText replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
  • 06:58, 25 October 2016 diff hist -92 m CNS lymphomaText replacement - "<span style="background:#ff0000; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Retrospective</span>" to "style="background-color:#ff0000"|Retrospective"
  • 06:58, 25 October 2016 diff hist -92 m Sickle cell anemiaText replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase III</span>" to "style="background-color:#00CD00"|Phase III"
  • 06:58, 25 October 2016 diff hist -92 m Transplant conditioning regimensText replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase I/II</span>" to "style="background-color:#EEEE00"|Phase I/II"
  • 06:56, 25 October 2016 diff hist -1,196 m Hepatocellular carcinomaText replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase III</span>" to "style="background-color:#00CD00"|Phase III"
  • 06:56, 25 October 2016 diff hist -8,096 m Colon cancerText replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase III</span>" to "style="background-color:#00CD00"|Phase III"
  • 06:56, 25 October 2016 diff hist -552 m Essential thrombocythemiaText replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase III</span>" to "style="background-color:#00CD00"|Phase III"
  • 06:56, 25 October 2016 diff hist -184 m Castleman diseaseText replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase III</span>" to "style="background-color:#00CD00"|Phase III"
  • 06:54, 25 October 2016 diff hist -92 m OsteosarcomaText replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Non-randomized</span>" to "style="background-color:#EEEE00"|Non-randomized"
  • 06:54, 25 October 2016 diff hist -368 m Transplant conditioning regimensText replacement - "<span style="background:#ff0000; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Retrospective</span>" to "style="background-color:#ff0000"|Retrospective"
  • 06:53, 25 October 2016 diff hist -92 m Aplastic anemiaText replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
  • 06:53, 25 October 2016 diff hist -276 m Polycythemia veraText replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase III</span>" to "style="background-color:#00CD00"|Phase III"
  • 06:52, 25 October 2016 diff hist -184 m Prostate cancerText replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Randomized Phase II</span>" to "style="background-color:#00CD00"|Randomized Phase II"
  • 06:52, 25 October 2016 diff hist -1,012 m Endometrial cancerText replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase III</span>" to "style="background-color:#00CD00"|Phase III"
  • 06:50, 25 October 2016 diff hist -92 m Atypical hemolytic uremic syndromeText replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Non-randomized</span>" to "style="background-color:#EEEE00"|Non-randomized"
  • 06:50, 25 October 2016 diff hist -92 m HIV-associated lymphomaText replacement - "<span style="background:#ff0000; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Retrospective</span>" to "style="background-color:#ff0000"|Retrospective"

(newest | oldest) View ( | ) (20 | 50 | 100 | 250 | 500)